Get notified of page updates
Glossary on
off
Clinicaltrials.gov identifier:
NCT05078866
Prevention study for people with Lynch syndrome
Cancer Prevention Vaccine (Nous-209) for People with Lynch Syndrome
About the Study
This study is no longer enrolling people.
This study is testing a vaccine, known as the Nous-209 vaccine, which is intended to decrease the chances that people with will develop that can turn into cancer.
People with who enroll in the study will participate for one year. It evaluates the safety and effectiveness of the Nous-209 vaccine in people affected with .
This Study is Open To:
This study is no longer enrolling people.
This Study is Not Open To:
This study is no longer enrolling people.